Long term follow-up data shows a sustained and improved (vs. week 20) benefit of potravitug on BK polyomavirus viral load in kidney transplant recipients at week 38 (study end). Potravitug was well to...
Read moreSPVN20 aims to restore visual acuity and aspects of color vision by creating an alternative light-signaling cascade in malfunctioning cone photoreceptors
Read moreTGW211 is a next-generation, first-in-class HER2-directed radioimmunoconjugate developed based on Tagworks’ proprietary Click-to-Release – bioorthogonal, in vivo click chemistry – linker platfor...
Read moreAM-Pharma B.V. today announced that it has successfully completed enrollment of patients in its ongoing Phase 2 clinical trial evaluating ilofotase alfa for the prevention of cardiac surgery-associate...
Read moreThe studies established the lead asset SYT-510 to be well tolerated in healthy volunteers at all doses with a good safety profile
Read moreThe study demonstrates how the MAF Test®, which stratifies early-stage breast cancer patients by MAF gene status to guide adjuvant bisphosphonate therapy, delivers meaningful economic value across mu...
Read moreFinanciación completa del ensayo de fase III del VMX-C001, desarrollo del producto en fase avanzada, fabricación y actividades previas al lanzamiento.
Read morePivotal Launch-HTN trial of novel aldosterone synthase inhibitor lorundrostat enrolled a diverse range of participants with uncontrolled or resistant hypertension
Read moreMinoryx Therapeutics today announce that the Marketing Authorization Application (MAA) for Minoryx’s lead candidate leriglitazone (NEZGLYAL®) has been submitted to the European Medicines Agency (EM...
Read moreFirst-of-its-kind heart pump implanted in Australia, based on a breakthrough wave membrane technology. Unlike existing devices, CorWave’s technology does not eliminate the effects of the native hear...
Read moreRPN-001 is a novel orally administered aromatase inhibitor being developed for the treatment of infertility in men with low serum testosterone
Read moreFirst patient received bilateral administration of NRTX-1001; no significant surgical complications or adverse events reported to date
Read more